We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
+13.01%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$234B
AUM Growth
+$27.2B
Cap. Flow
+$4.48B
Cap. Flow %
1.91%
Top 10 Hldgs %
17.69%
Holding
6,610
New
800
Increased
2,296
Reduced
2,513
Closed
633

Top Sells

Rank Stock Value
1
APP icon
Applovin
APP
+$1.19B
2
PLTR icon
Palantir
PLTR
+$742M
3
HES
Hess
HES
+$478M
4
ORCL icon
Oracle
ORCL
+$465M
5
TRI icon
Thomson Reuters
TRI
+$442M

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Financials 7.68%
3 Healthcare 6.5%
4 Industrials 5.87%
5 Consumer Discretionary 4.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMCR icon
6101
CALL
Immunocore
IMCR
$1.72B
-15,000
Closed -$471K
IMVT icon
6102
CALL
Immunovant
IMVT
$8.11B
-50,000
Closed -$800K
INDV icon
6103
CALL
Indivior Pharmaceuticals
INDV
$4.75B
-107,200
Closed -$1.58M
INMB icon
6104
INmune Bio
INMB
$47.1M
-42,612
Closed -$98.4K
INMB icon
6105
PUT
INmune Bio
INMB
$47.1M
-50,000
Closed -$116K
INOD icon
6106
Innodata
INOD
$1.96B
-12,466
Closed -$630K
INSE icon
6107
Inspired Entertainment
INSE
$182M
-24,265
Closed -$198K
INSG icon
6108
Inseego
INSG
$111M
-14,447
Closed -$119K
INSM icon
6109
CALL
Insmed
INSM
$22B
-8,000
Closed -$805K
INSP icon
6110
CALL
Inspire Medical Systems
INSP
$1.44B
-15,200
Closed -$1.97M
INSP icon
6111
PUT
Inspire Medical Systems
INSP
$1.44B
-12,200
Closed -$1.58M
INZY
6112
DELISTED
Inozyme Pharma
INZY
-481,799
Closed -$1.93M
IONQ icon
6113
CALL
IonQ
IONQ
$13.4B
-8,100
Closed -$348K
IONQ icon
6114
PUT
IonQ
IONQ
$13.4B
-14,500
Closed -$623K
IPHA
6115
Innate Pharma
IPHA
$164M
-11,661
Closed -$20.4K
IQ icon
6116
iQIYI
IQ
$1.24B
-462,791
Closed -$819K
IRON icon
6117
CALL
Disc Medicine
IRON
$3.03B
-15,000
Closed -$794K
ISTR icon
6118
Investar Holding Corp
ISTR
$411M
-29,889
Closed -$577K
ITA icon
6119
iShares US Aerospace & Defense ETF
ITA
$14.1B
-3,655
Closed -$689K
ITB icon
6120
PUT
iShares US Home Construction ETF
ITB
$2.29B
-134,200
Closed -$12.5M
ITOS
6121
CALL
DELISTED
iTeos Therapeutics
ITOS
-342,500
Closed -$3.41M
ITOS
6122
DELISTED
iTeos Therapeutics
ITOS
-477,189
Closed -$4.76M
ITRI icon
6123
CALL
Itron
ITRI
$4.33B
-7,600
Closed -$1M
IWB icon
6124
iShares Russell 1000 ETF
IWB
$47.9B
-6,955
Closed -$2.36M
IWN icon
6125
iShares Russell 2000 Value ETF
IWN
$14.4B
-4,843
Closed -$764K

Similar funds

Millennium Management's Q3 2025 Portfolio in Review

As of Q3 2025, Millennium Management held 6,610 positions worth $234B, up 13% from $207B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Millennium Management's Q3 2025 filing shows 800 new, 2,296 increased, 2,513 reduced and 633 closed positions. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M. The largest sale was Applovin, an estimated $1.19B.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 8.7% a quarter earlier, followed by Financials and Healthcare.

  • Millennium Management's largest Q3 2025 buy was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M.
  • Millennium Management added most to NVIDIA in Q3 2025, an estimated $1.78B increase.
  • Millennium Management's biggest Q3 2025 reduction was Applovin, cutting an estimated $1.19B.
  • Millennium Management fully exited Hess in Q3 2025, selling an estimated $478M.
  • Millennium Management's ten largest holdings make up 18% of its $234B portfolio in Q3 2025.
  • Millennium Management opened 800 new positions and closed 633 in Q3 2025.
  • Millennium Management's portfolio value rose 13% quarter-over-quarter to $234B.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.